This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!
FDA urged to rely more on advisory panels for new drugs
A presidential advisory panel recommended that the FDA depend more on its expert committees when approving experimental therapies. The panel backed faster cancer and AIDS drug approvals, broader criteria beyond survival, and restructuring to empower advisory panels with independent staff and direct reporting to the commissioner.
MENTIONED IN THIS ARTICLE
Washington
Food and Drug Administration
Armand Hammer
FDA
Secretary of Health and Human Services